Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoadjuvant Therapy × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 23 Breast Neoplasms 22 Colorectal Neoplasms 14 Ovarian Neoplasms 12 Lung Neoplasms 10 Neoplasm Metastasis 9 Stomach Neoplasms 8 Neoplasms 8 Nasopharyngeal Carcinoma 8 Leukemia, Myeloid, Acute 7 Squamous Cell Carcinoma of Head and Neck 6 Rectal Neoplasms 6 Fallopian Tube Neoplasms 6 Triple Negative Breast Neoplasms 5 Recurrence 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Esophageal Squamous Cell Carcinoma 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Pancreatic Neoplasms 3 Neoplasms by Site 3 Lymphoma, Large B-Cell, Diffuse 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Multiple Myeloma 2

Interventions

famitinib 1 Neoadjuvant Therapy 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06913777 2025-06-06

Neoadjuvant SNF Precision Therapy Phase III

Fudan University

Phase 3 Recruiting

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡